{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:26:18Z","timestamp":1778883978767,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["19H01045"],"award-info":[{"award-number":["19H01045"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["19K17037"],"award-info":[{"award-number":["19K17037"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jns.2019.116619","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T11:51:26Z","timestamp":1575633086000},"page":"116619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis"],"prefix":"10.1016","volume":"409","author":[{"given":"Takayuki","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukino","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guzailiayi","family":"Maimaitijiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116619_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.116619_bb0010","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1212\/WNL.0b013e3181e3973f","article-title":"New perspectives in the natural history of multiple sclerosis","volume":"74","author":"Tremlett","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116619_bb0015","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.jns.2019.116619_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI14452","article-title":"Autoantibodies as predictors of disease","volume":"108","author":"Leslie","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2019.116619_bb0025","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Br\u00e4ndle","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2019.116619_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/rheumatology\/39.6.581","article-title":"Antinuclear antibodies: cause of disease or caused by disease?","volume":"39","author":"Smeenk","year":"2000","journal-title":"Rheumatology."},{"key":"10.1016\/j.jns.2019.116619_bb0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1352458517706037","article-title":"Multiple sclerosis: Serum anti-CNS autoantibodies","volume":"24","author":"Prineas","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.116619_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116619_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116619_bb0050","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116619_bb0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116619_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.410400405","article-title":"Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders","volume":"40","author":"Kira","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116619_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1352458517707067","article-title":"HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis","volume":"24","author":"Shinoda","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.116619_bb0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.25279","article-title":"A Novel Autoantibody against Plexin D1 in Patients with Neuropathic Pain","volume":"84","author":"Fujii","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116619_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0039.2008.01172.x","article-title":"Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders","volume":"73","author":"Matsushita","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2019.116619_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12974-016-0695-3","article-title":"Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study","volume":"13","author":"Nakamura","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.116619_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bpa.12386","article-title":"Early and extensive spinal white matter involvement in neuromyelitis optica","volume":"27","author":"Hayashida","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2019.116619_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.jns.2019.116619_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.4239","article-title":"Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis","author":"Naegelin","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.116619_bb0100","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.jns.2019.116619_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23721","article-title":"Cognitive impairment and cortical degeneration in neuromyelitis optica","volume":"73","author":"Saji","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116619_bb0110","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/WNL.58.9.1372","article-title":"Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit","volume":"58","author":"Silber","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116619_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/135245859800400304","article-title":"The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.116619_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0812-y","article-title":"Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study","volume":"14","author":"Farina","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.116619_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/brain\/awn301","article-title":"Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures","volume":"132","author":"Okuda","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.jns.2019.116619_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/nan.12165","article-title":"The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis","volume":"41","author":"Yates","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:49:35Z","timestamp":1758383375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19323846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":26,"alternative-id":["S0022510X19323846"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116619","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116619"}}